Lonza expands manufacturing with bottling and labeling at US site
WEBAug 15, 2024 · Lonza, a global leader in the pharmaceutical, biotech, and nutraceutical markets, has installed advanced bottling and labeling equipment at its small molecules site in Bend, Oregon. The new equipment is designed to handle solid dosage forms, such as tablets and powder-filled capsules, for early-phase clinical trials.
Premier Research: holistic approach benefits development
WEBOct 6, 2020 · Learn how Premier Research, a CRO, uses a holistic strategy to design and execute drug development programs. The article covers target product profile, multi-target drug discovery, regulatory feedback, and patient centricity.
The rise of the integrated research organization: A conversation …
WEBSep 11, 2019 · Behind the term is NC-based Javara, which made its official debut in June 2018 . The company’s CEO Jennifer Byrne told us the name ‘integrated research organization,’ or IRO, emerged as the descriptor for the new clinical research model following discussions with Wake Forest Baptist Health.
DFE Pharma, Harro Höfliger, and Sterling forge partnership
WEBApr 6, 2022 · A trio of companies—excipients provider DFE Pharma, equipment supplier Harro Höfliger, and active pharmaceutical ingredient (API) manufacturer Sterling—have forged a partnership intended to advance dry-powder inhalation (DPI) solutions. Named Inhalation Together (INTO), the collaboration will strive to formulate respiratory treatments.
Lonza opens early-phase development, manufacturing facility
WEBJun 14, 2022 · Lonza, a Switzerland-based service provider, has invested in a new facility in Oregon to offer early clinical phase capabilities for drug development. The facility features spray drying, granulation, tablet press and coater equipment, and …
ICON to acquire PRA Health Sciences in $12b deal
WEBFeb 25, 2021 · ICON, a Dublin-based contract research organization (CRO) has entered into an agreement to acquire PRA Health Sciences, another CRO currently sited in Raleigh, North Carolina. The arrangement comprises a cash and stock transaction valued at approximately $12bn USD. According to company leaders, the transaction stands to benefit pharmaceutical ...
3M Drug Delivery Systems relaunches as Kindeva Drug Delivery
WEBMay 4, 2020 · 3M Drug Delivery Systems relaunches as Kindeva Drug Delivery. News and analysis on clinical trial services and contract research and development. The launch of the renamed, newly independent company follows its acquisition by Altaris Capital Partners. After selling its drug delivery systems to Altaris in a transaction valued at $650m (£523 ...
ANI Pharmaceuticals acquires Amerigen’s commercial products
WEBJan 13, 2020 · ANI acquires the 23 generic products from Amerigen to expand its commercial offering in the US. The deal sees ANI Pharmaceuticals pay $52.5m (€47.2m) Amerigen Pharmaceuticals in cash, with an additional $25m in contingent profit share payments to be made over the next four years. Through …
Overcoming Challenges of Clinical Data Review
WEBJun 10, 2021 · Clinical data review is intrinsic to clinical development, assuring patient safety, determining drug efficacy, and assessing data quality. It involves rigorous analysis of a wide variety of clinical trial data and often necessitates data integration from multiple sources to extract actionable insights. Learn about the common challenges of clinical data review that stall clinical trials and the ...
Excipients, raw materials & intermediates
WEBThe raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success. Continuous Manufacturing Technology continues to gain importance in pharmaceutical manufacturing. Formulation of bi-layer or multi-layer tablets enables the combination of two or more drugs that may be ...